Personalis, Inc. Long-term Line of Credit
Personalis, Inc. (PSNL) had Long-term Line of Credit of $20.00 million as of 2019-06-30, per its 10-Q filed 2019-08-13.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LineOfCredit · last filed 2020-03-25
- 2019-06-30: Long-term Line of Credit $20.00M.
- 2018-12-31: Long-term Line of Credit $5.00M.
| Period end | Long-term Line of Credit |
|---|---|
| 2019-06-30 | $20.00M 10-Q · filed 2019-08-13 |
| 2018-12-31 | $5.00M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |